39106-79-1

Basic information

• Product Name: METHYL 2-METHOXY-4-NITROBENZOATE
• Synonyms: METHYL 2-METHOXY-4-NITROBENZOATE
• CAS NO: 39106-79-1
• Molecular Formula: C₉H₉NO₅
• Molecular Weight: 211.17146
• Product Categories: Aromatic Esters
• Mol File: 39106-79-1.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 350.745°C at 760 mmHg
• Flash Point: 168.345°C
• Appearance: /
• Density: 1.294g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.541
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL 2-METHOXY-4-NITROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-METHOXY-4-NITROBENZOATE(39106-79-1)
• EPA Substance Registry System: METHYL 2-METHOXY-4-NITROBENZOATE(39106-79-1)

Safety Data

• Hazardous Substances Data: 39106-79-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H9NO5/c1-14-8-5-6(10(12)13)3-4-7(8)9(11)15-2/h3-5H,1-2H3

Upstream product

• 619-19-2 2-hydroxy-4-nitrobenzoic acid 
• 80-18-2 Methyl benzenesulfonate 
• 186581-53-3 diazomethane 
• 2597-56-0 4-nitro-o-anisic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 
• 77-78-1 dimethyl sulfate 
• 27492-84-8 Methyl 4-amino-2-methoxybenzoate 
• 101084-96-2 2-methoxy-4-nitrobenzonitrile 
• 80-48-8 methyl p-toluene sulfonate 
• 13684-28-1 2-hydroxy-4-nitro-benzoic acid methyl ester 

Downstream Products

• 1285539-30-1 2-methoxy-4-nitro-N-(4-trifluoromethylphenyl)benzamide 
• 200879-07-8 [3-Methoxy-4-(5H,11H-pyrrolo[2,1-c][1,4]-benzodiazepine-10-carbonyl)-phenyl]-biphenyl-2-carboxylic acid-amide 
• 207670-33-5 10-(4-[(biphenyl-2-carbonyl)-amino]-2-methoxy-benzoyl)-10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-3-carboxylic acid-1,1-dimethylhydrazide 
• 207670-43-7 N-[[5-[3-trichloromethylcarbonyl]-[5H-pyrrolo-[2,1-c][1,4]-benzodiazepin-10(11H)-yl]carbonyl]-2-methoxyphenyl]-2-phenylbenzamide 
• 200879-10-3 4-[(biphenyl-2-carbonyl)-amino]-2-methoxy-benzoic acid 
• 200879-09-0 4-[(biphenyl-2-carbonyl)-amino]-2-methoxy-benzoic acid methyl ester 
• 205448-65-3 7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid methyl ester 
• 4093-34-9 2-Methoxy-4-cetamino-5-brom-benzoesaeuremethylester 
• 4093-29-2 methyl 4-(acetylamino)-o-anisate 
• 136507-15-8 4-nitro-2-methoxybenzaldehyde 
• 2460-58-4 2-hydroxy-4-nitrobenzaldehyde 
• 1314003-25-2 buprenorphine-(2-methoxy-PABA) carbamate hydrochloride 
• 1314003-75-2 buprenorphine-(2-methoxy-PABA) benzyl ester carbamate 
• 1314003-74-1 C₁₆H₁₃NO₄ 

Relevant articles and documents

2,4-Pyrimidinediamine Compounds and Their Uses

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

PRODRUGS OF OPIOIDS AND USES THEREOF

The present invention concerns prodrugs of opioid analgesics and pharmaceutical compositions containing such prodrugs. Methods for providing more consistent pain relief by increasing the bioavailability of the opioid analgesic with the aforementioned prodrugs are provided. The invention also provides for decreasing the adverse GI side effects of opioid analgesics.

RADIOHALOGENATED BENZAMIDE DERIVATIVES AND THEIR USE IN TUMOR DIAGNOSIS AND TUMOR THERAPY

This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.